Alpha Cognition, Inc
ACOG · Vancouver, British Columbia, Canada
Works in Neurology · Psychiatry
Alpha Cognition, Inc is a clinical trial sponsor based in Vancouver, British Columbia, Canada, listed as ACOG. It has 1 active clinical trial with 150 planned participants, in Neurology and Psychiatry.
Trial track record · since 2021
Financials · ACOG
Fundraising
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
On the market
1 approved drug application with a product on the market.
Questions about Alpha Cognition, Inc
Alpha Cognition, Inc is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 150 planned participants, in Neurology, Psychiatry. Since 2021 it has completed 0 trials and stopped 0 early.
Alpha Cognition, Inc is based in Vancouver, British Columbia, Canada and is listed as ACOG. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Alpha Cognition, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-25.
Approve Suite is not affiliated with Alpha Cognition, Inc.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.